Oncolytics Biotech(R) announces public offering of common shares and warrants
Oncolytics Biotech® announced it intends to offer to sell common shares and warrants to purchase common shares in an underwritten public offering. The Company expects to grant underwriter a 30-day option to purchase additional common shares and warrants to purchase common shares. August 13, 2019
